223 related articles for article (PubMed ID: 31935626)
1. Tocilizumab in pediatric refractory status epilepticus and acute epilepsy: Experience in two patients.
Cantarín-Extremera V; Jiménez-Legido M; Duat-Rodríguez A; García-Fernández M; Ortiz-Cabrera NV; Ruiz-Falcó-Rojas ML; González-Gutiérrez-Solana L
J Neuroimmunol; 2020 Mar; 340():577142. PubMed ID: 31935626
[TBL] [Abstract][Full Text] [Related]
2. Second-line immunotherapy in new onset refractory status epilepticus.
Hanin A; Muscal E; Hirsch LJ
Epilepsia; 2024 May; 65(5):1203-1223. PubMed ID: 38430119
[TBL] [Abstract][Full Text] [Related]
3. Tocilizumab treatment for new onset refractory status epilepticus.
Jun JS; Lee ST; Kim R; Chu K; Lee SK
Ann Neurol; 2018 Dec; 84(6):940-945. PubMed ID: 30408233
[TBL] [Abstract][Full Text] [Related]
4. Cryptogenic new-onset refractory status epilepticus responded to anti-interleukin-6 treatment.
Wadayama T; Shimizu M; Yata T; Ishikura T; Kajiyama Y; Hirozawa D; Okuno T; Mochizuki H
J Neuroimmunol; 2022 Feb; 363():577789. PubMed ID: 34973472
[TBL] [Abstract][Full Text] [Related]
5. Treatment of new onset refractory status epilepticus/febrile infection-related epilepsy syndrome with tocilizumab in a child and a young adult.
Girardin ML; Flamand T; Roignot O; Abi Warde MT; Mutschler V; Voulleminot P; Guillot M; Dinkelacker V; De Saint-Martin A
Epilepsia; 2023 Jun; 64(6):e87-e92. PubMed ID: 36961094
[TBL] [Abstract][Full Text] [Related]
6. Febrile infection-related epilepsy syndrome (FIRES) with super-refractory status epilepticus revealing autoimmune encephalitis due to GABA
Caputo D; Iorio R; Vigevano F; Fusco L
Eur J Paediatr Neurol; 2018 Jan; 22(1):182-185. PubMed ID: 29203057
[TBL] [Abstract][Full Text] [Related]
7. Anakinra and tocilizumab in the chronic phase of febrile infection-related epilepsy syndrome (FIRES): Effectiveness and safety from a case-series.
Aledo-Serrano A; Hariramani R; Gonzalez-Martinez A; Álvarez-Troncoso J; Toledano R; Bayat A; Garcia-Morales I; Becerra JL; Villegas-Martínez I; Beltran-Corbellini A; Gil-Nagel A
Seizure; 2022 Aug; 100():51-55. PubMed ID: 35759951
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of potassium bromide in the treatment of drug-resistant epilepsy: a case of new-onset refractory status epilepticus].
Takei J; Takei R; Nozuma S; Nakahara K; Watanabe O; Takashima H
Rinsho Shinkeigaku; 2016 Nov; 56(11):759-763. PubMed ID: 27773903
[TBL] [Abstract][Full Text] [Related]
9. Treatment of COVID-19-induced refractory status epilepticus by tocilizumab.
Kizilkilic EK; Unkun R; Uygunoglu U; Delil S; Ozkara C
Eur J Neurol; 2022 Sep; 29(9):2861-2863. PubMed ID: 35678591
[TBL] [Abstract][Full Text] [Related]
10. Successful Treatment of Pediatric FIRES With Anakinra.
Yang JH; Nataraj S; Sattar S
Pediatr Neurol; 2021 Jan; 114():60-61. PubMed ID: 33227629
[No Abstract] [Full Text] [Related]
11. Interleukin-6 as an inflammatory mediator and target of therapy in chronic periaortitis.
Vaglio A; Catanoso MG; Spaggiari L; Magnani L; Pipitone N; Macchioni P; Pulsatelli L; Nicastro M; Becchi G; Corradi D; Versari A; Boiardi L; Salvarani C
Arthritis Rheum; 2013 Sep; 65(9):2469-75. PubMed ID: 23740665
[TBL] [Abstract][Full Text] [Related]
12. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions.
Hirsch LJ; Gaspard N; van Baalen A; Nabbout R; Demeret S; Loddenkemper T; Navarro V; Specchio N; Lagae L; Rossetti AO; Hocker S; Gofton TE; Abend NS; Gilmore EJ; Hahn C; Khosravani H; Rosenow F; Trinka E
Epilepsia; 2018 Apr; 59(4):739-744. PubMed ID: 29399791
[TBL] [Abstract][Full Text] [Related]
13. Effective use of tocilizumab for the treatment of steroid-refractory gastrointestinal acute graft versus host disease in a child with very high levels of serum interleukin-6.
Kolb M; Bhatia M; Madina GG; Satwani P
Pediatr Blood Cancer; 2015 Feb; 62(2):362-363. PubMed ID: 25212196
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of lacosamide in children and adolescents with drug-resistant epilepsy and refractory status epilepticus: A systematic review.
Ortiz de la Rosa JS; Ladino LD; Rodríguez PJ; Rueda MC; Polanía JP; Castañeda AC
Seizure; 2018 Mar; 56():34-40. PubMed ID: 29428899
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases.
Gofshteyn JS; Wilfong A; Devinsky O; Bluvstein J; Charuta J; Ciliberto MA; Laux L; Marsh ED
J Child Neurol; 2017 Jan; 32(1):35-40. PubMed ID: 27655472
[TBL] [Abstract][Full Text] [Related]
16. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives.
Gaspard N; Hirsch LJ; Sculier C; Loddenkemper T; van Baalen A; Lancrenon J; Emmery M; Specchio N; Farias-Moeller R; Wong N; Nabbout R
Epilepsia; 2018 Apr; 59(4):745-752. PubMed ID: 29476535
[TBL] [Abstract][Full Text] [Related]
17. Febrile infection-related Epilepsy Syndrome (FIRES): a severe encephalopathy with status epilepticus. Literature review and presentation of two new cases.
Pavone P; Corsello G; Raucci U; Lubrano R; Parano E; Ruggieri M; Greco F; Marino S; Falsaperla R
Ital J Pediatr; 2022 Dec; 48(1):199. PubMed ID: 36527084
[TBL] [Abstract][Full Text] [Related]
18. Drug-resistant seizures associated with hyperinflammatory monocytes in FIRES.
Howe CL; Johnson RK; Overlee BL; Sagen JA; Mehta N; Farias-Moeller R
Ann Clin Transl Neurol; 2023 May; 10(5):719-731. PubMed ID: 36924141
[TBL] [Abstract][Full Text] [Related]
19. High dose cannabidiol (CBD) in the treatment of new-onset refractory status epilepticus (NORSE).
Aydemir S; Kandula P
Seizure; 2022 Jan; 94():126-128. PubMed ID: 34896815
[No Abstract] [Full Text] [Related]
20. Interleukin-1 receptor is a target for adjunctive control of diazepam-refractory status epilepticus in mice.
Xu ZH; Wang Y; Tao AF; Yu J; Wang XY; Zu YY; Zhang SH; Chen Z
Neuroscience; 2016 Jul; 328():22-9. PubMed ID: 27133574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
